Lactoferrin Supplementation Acne Randomized Trial: What the Evidence Says

Quick Answer

Lactoferrin Supplementation Acne Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Cutibacterium acnes Propionibacterium acnes 6 7 The pathogenesis of acne is multifactorial, arising from the interplay of increased sebum production, abnormal follicular keratinization, colonization with(formerly), and inflammation with contributions from genetic, hormonal, and environmental factors. [Warp Peyton V. (2026); evidence level 1]
• Limited studies of gut microbiota in patients with acne have identified overall reduced diversity, a higher Bacteroidetes:Firmicutes ratio, enrichment of Proteobacteria, depletion of Actinobacteria, and loss of beneficial genera, includingand. [Warp Peyton V. (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For lactoferrin supplementation acne randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Warp Peyton V. (2026). Prebiotics, Probiotics, and Postbiotics for Acne Vulgaris: A Systematic Review. DOI: 10.1007/s13555-026-01659-4. PMCID: PMC13013907. PMID: 41703218. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This article is licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13013907/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.